Company Filing History:
Years Active: 2023-2025
Title: The Innovative Contributions of Gia Hoang
Introduction
Gia Hoang is a notable inventor based in Wilmington, DE (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of three patents to his name, he has made strides in developing compounds that target critical biological pathways associated with various diseases.
Latest Patents
One of Gia Hoang's latest patents is focused on quinoline compounds as inhibitors of KRAS. This patent discloses compounds of Formula I, which are designed to inhibit KRAS activity. These compounds are particularly useful in treating, preventing, or ameliorating diseases associated with KRAS activity, such as cancer. Another significant patent involves fused pyrazine derivatives as A2A/A2B inhibitors. This application relates to compounds of Formula (I) or pharmaceutically acceptable salts thereof, which modulate the activity of adenosine receptors, including subtypes A2A and A2B. These compounds are beneficial in treating diseases related to adenosine receptor activity, including cancer, inflammatory diseases, cardiovascular diseases, and neurodegenerative diseases.
Career Highlights
Gia Hoang is currently employed at Incyte Corporation, where he continues to innovate and contribute to the development of new therapeutic agents. His work is characterized by a strong focus on addressing complex medical challenges through innovative chemical solutions.
Collaborations
Gia collaborates with talented coworkers, including Xiaozhao Wang and Wenqing Yao, who contribute to the research and development efforts at Incyte Corporation.
Conclusion
Gia Hoang's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His patents not only advance scientific knowledge but also hold the potential to improve treatment options for patients suffering from serious health conditions.